Decode News AI
简体繁體

Isomorphic Labs Raises $5 Billion Series C to Advance AI Drugs to Trials

2026-11-17 13:29 EST · AI-compiled · 275 words · about 1 min · Views …
Photo: AI-generated illustration

LONDON - Alphabet spinout Isomorphic Labs announced on Nov. 17 that it raised $5 billion in Series C funding, just six months after closing a $2.1 billion Series B round in May. The London-based artificial intelligence drug developer plans to move its preclinical programs into human clinical trials.

Major Investors Back Record Biotech Round

"Isomorphic Labs announces it has raised $5 Billion in Series C funding. The round was co-led by Greenoaks and Sequoia Capital, alongside Andreessen Horowitz (a16z) and several other new investors, with continued significant investment from Alphabet," the company stated on Nov. 17. Existing backers Thrive Capital, MGX, GV, CapitalG, Temasek, and the UK Sovereign AI Fund also participated. According to BioPharma Dive, the financing marks the largest private biotech venture round tracked since 2022 despite broader tech market volatility.

Proprietary Engine Targets Oncology and Immunology

President Max Jaderberg said in a statement that the company's machine learning researchers and drug hunters "are routinely solving complex biological problems that have stalled traditional research for decades." Isomorphic is scaling its proprietary IsoDDE drug design engine, which it says outperforms AlphaFold 3 on protein-ligand structure benchmarks. While the company cited positive preclinical results in oncology and immunology, it has not yet published detailed experimental data.

Leadership Shift and Pharma Partnerships

The financing is the first since founder and CEO Demis Hassabis stepped down as head of Google DeepMind to become DeepMind chairman and focus on drug discovery. Spun out in 2021, Isomorphic signed alliances with Eli Lilly and Novartis worth about $3 billion in 2024 and added Johnson & Johnson in early 2026. The company did not disclose its post-money valuation.

Sources

Found a factual error or typo? Tell us

Follow Decode News AI on Telegram

Live updates: every new story is pushed the moment it publishes — dozens a day, no digest delay.

@decodenewsai · Subscribe now

Free · unsubscribe anytime

Comments